Browsing Tag

Anifrolumab

ACR: Long-Term Safety Demonstrated for Anifrolumab in Lupus

Jason Junior Nov 22, 2022

Elana Gotkine MONDAY, Nov. 21, 2022 (HealthDay News) -- For patients with systemic lupus erythematosus (SLE), anifrolumab is safe in the long term, according to a study published online Nov. 11 in…

Health

Thumbs Up From FDA for Anifrolumab in Lupus

Jason Junior Aug 3, 2021

The FDA has approved the type 1 interferon receptor antagonist anifrolumab (Saphnelo) for the treatment of moderate-to-severe systemic lupus…